Additionally, TMEV-infected, anti-GR-1 Ab-treated mice had decreased myelin-specific CD4+ T cell responses compared to control Ab-treated mice during the demyelinating disease at a later time post-infection (97). This evidence concerns the gene CD4 and demyelinating disease.